STING1 and neoplasm: This indicates that the contribution of cGAS-STING signaling to the BRCA1/2–PARPi SL is not tumor cell-autonomous (i.e., it relies on non-tumor cell lineages) and is best explained by cGAS-STING signaling activating a T-cell-mediated immune response17,18.